Recombinant Human Anti-CD15 x Human Anti-CD64 Bispecific Antibody (Fab-scFv-Fc) (FABVC-H209)

Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Fab-scFv-Fc) requires expression of three polypeptide chains, encoding two heavy chains (Fc-containing chains) and one light chain, respectively. The Fab of anti-CD15 antibody variable domain is fused to the Fc-knob domain with a hinge region and the same as the scFv of anti-CD64 to the Fc-hole domain, or vice versa. The Fab-Fc and scFv-Fc fragments can be paired via the interaction of the Fc regions. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of Leukemia therapy.

Datasheet INQUIRY

Specifications

Targets

CD15 & CD64

Type

Fab-Fc Fusion Proteins

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Leukemia

Targets

Target 1

CD15

Gene ID

2526

UniProt ID

P22083

Alternative Names

FUT4; fucosyltransferase 4; LeX; CD15; ELFT; FCT3A; FUTIV; SSEA-1; FUC-TIV; 3-FAL; 3-fucosyl-N-acetyllactosamine; stage-specific embryonic antigen-1; Lewis X; X-hapten

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD15 x Human Anti-CD64 Bispecific Antibody (Fab-scFv-Fc) (FABVC-H209). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD15 x Human Anti-CD64 Bispecific Antibody (Fab-scFv-Fc) (CAT#: FABVC-H209)

Specifications

Targets

Customer Reviews and Q&As